◆英語タイトル:Neos Therapeutics Inc (NEOS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9833
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded pharmaceuticals. The company’s portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years age and older; and Tussionex that is indicated for cough and upper respiratory symptoms of cold. Its pipeline encompasses investigational candidates for the treatment of ADHD. Neos Therapeutics’ products are orally disintegrating tablets (ODT) or liquid suspension dosage forms, which are based on its proprietary extended-release (XR) drug delivery technology platform. The company also manufactures and markets its generic equivalent of the branded product Tussionex. Neos Therapeutics is headquartered in Grand Prairi, Texas, the US.
Neos Therapeutics Inc (NEOS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neos Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Neos Therapeutics Acquires Tussionex from Chiesi and Coating Place 10
Venture Financing 11
Neos Therapeutics Raises USD20.6 Million in Venture Financing 11
Neos Therapeutics Raises USD8 Million in Venture Financing 12
Neos Therapeutics Raises US$2.5 Million In Venture Financing 13
Neos Therapeutics Raises US$7.4 Million In Series C Financing 14
Neos Therapeutics Raises US$8 Million In Venture Financing 15
Neos Therapeutics Raises US$18.3 Million In Venture Financing 16
Licensing Agreements 17
Neos Therapeutics Enters into Licensing Agreement with NeuRx Pharma 17
Neos Therapeutics Enters into Licensing Agreement with Shire 18
Equity Offering 19
Neos Therapeutics Prices Public Offering of Shares for USD40 Million 19
Neos Therapeutics Raises USD30 million in Public Offering of Shares 21
Neos Therapeutics Raises USD25 million in Public Offering of Shares 22
Neos Therapeutics Files Registration Statement for Public Offering of Shares for USD69 Million 24
Neos Therapeutics Raises USD82.8 Million in IPO 25
Neos Therapeutics Inc – Key Competitors 27
Neos Therapeutics Inc – Key Employees 28
Neos Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Financial Announcements 30
Aug 08, 2018: Keryx Biopharmaceuticals Announces Second Quarter 2018 Financial Results 30
Aug 08, 2018: Neos Therapeutics Reports Second Quarter 2018 Financial Results 31
May 09, 2018: Neos Therapeutics Reports First Quarter 2018 Financial Results 32
Mar 15, 2018: Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results 34
Aug 08, 2017: Neos Therapeutics Reports Second Quarter 2017 Financial Results 36
May 09, 2017: Neos Therapeutics Reports First Quarter 2017 Financial Results 37
Mar 14, 2017: Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results 38
Corporate Communications 40
Jun 27, 2018: Neos Therapeutics Names Jerry McLaughlin As Chief Executive Officer 40
Other Significant Developments 41
Feb 20, 2018: Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neos Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neos Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neos Therapeutics Acquires Tussionex from Chiesi and Coating Place 10
Neos Therapeutics Raises USD20.6 Million in Venture Financing 11
Neos Therapeutics Raises USD8 Million in Venture Financing 12
Neos Therapeutics Raises US$2.5 Million In Venture Financing 13
Neos Therapeutics Raises US$7.4 Million In Series C Financing 14
Neos Therapeutics Raises US$8 Million In Venture Financing 15
Neos Therapeutics Raises US$18.3 Million In Venture Financing 16
Neos Therapeutics Enters into Licensing Agreement with NeuRx Pharma 17
Neos Therapeutics Enters into Licensing Agreement with Shire 18
Neos Therapeutics Prices Public Offering of Shares for USD40 Million 19
Neos Therapeutics Raises USD30 million in Public Offering of Shares 21
Neos Therapeutics Raises USD25 million in Public Offering of Shares 22
Neos Therapeutics Files Registration Statement for Public Offering of Shares for USD69 Million 24
Neos Therapeutics Raises USD82.8 Million in IPO 25
Neos Therapeutics Inc, Key Competitors 27
Neos Therapeutics Inc, Key Employees 28
List of Figures
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8